Cite

HARVARD Citation

    Diesch, J. et al. (2016). A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers. Clinical epigenetics. 8 (1), pp. 1-11. [Online]. 
  
Back to record